Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition
Abstract Background Alzheimer's disease (AD) is the most common neurodegenerative disorder without effective therapy and lack diagnosis strategy for preclinical AD patients. There is an urgent need for development of both early diagnosis and therapeutic intervention of AD. Results Herein, we de...
Main Authors: | Ruan, Yuting (Author), Xiong, Ying (Author), Fang, Wenli (Author), Yu, Qun (Author), Mai, Yingren (Author), Cao, Zhiyu (Author), Wang, Kexi (Author), Lei, Ming (Author), Xu, Jiaxin (Author), Liu, Yan (Author), Zhang, Xingcai (Author), Liao, Wang (Author), Liu, Jun (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central,
2022-07-18T12:06:31Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Cancer Nanotheranostics
by: Kamolrat Thanapprapasr
Published: (2014-10-01) -
Nanotheranostics Targeting the Tumor Microenvironment
by: Catarina Roma-Rodrigues, et al.
Published: (2019-08-01) -
Multimodality imaging in nanomedicine and nanotheranostics
by: Xue Li, et al.
Published: (2016-09-01) -
Nanotheranostics: For P4 medicine
by: Suchetha N Malleshi
Published: (2017-01-01) -
Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
by: Hao Cai, et al.
Published: (2021-02-01)